These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33963932)

  • 1. The role of metabolic reprogramming and de novo amino acid synthesis in collagen protein production by myofibroblasts: implications for organ fibrosis and cancer.
    Hamanaka RB; Mutlu GM
    Amino Acids; 2021 Dec; 53(12):1851-1862. PubMed ID: 33963932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine Metabolism Is Required for Collagen Protein Synthesis in Lung Fibroblasts.
    Hamanaka RB; O'Leary EM; Witt LJ; Tian Y; Gökalp GA; Meliton AY; Dulin NO; Mutlu GM
    Am J Respir Cell Mol Biol; 2019 Nov; 61(5):597-606. PubMed ID: 30973753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts.
    Satyanarayana G; Turaga RC; Sharma M; Wang S; Mishra F; Peng G; Deng X; Yang J; Liu ZR
    Theranostics; 2021; 11(19):9331-9341. PubMed ID: 34646373
    [No Abstract]   [Full Text] [Related]  

  • 4. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Myofibroblasts in Physiological and Pathological Tissue Repair.
    Schuster R; Younesi F; Ezzo M; Hinz B
    Cold Spring Harb Perspect Biol; 2023 Jan; 15(1):. PubMed ID: 36123034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis.
    Henderson J; Duffy L; Stratton R; Ford D; O'Reilly S
    J Cell Mol Med; 2020 Dec; 24(23):14026-14038. PubMed ID: 33140521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular players in lung fibrosis.
    Lekkerkerker AN; Aarbiou J; van Es T; Janssen RA
    Curr Pharm Des; 2012; 18(27):4093-102. PubMed ID: 22630084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPRC5B promotes collagen production in myofibroblasts.
    Takizawa N; Hironaka T; Mae K; Ueno T; Horii Y; Nagasaka A; Nakaya M
    Biochem Biophys Res Commun; 2021 Jul; 561():180-186. PubMed ID: 34023784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic requirements of pulmonary fibrosis: role of fibroblast metabolism.
    Hamanaka RB; Mutlu GM
    FEBS J; 2021 Nov; 288(22):6331-6352. PubMed ID: 33393204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IκB kinase inhibitor ACHP strongly attenuates TGFβ1-induced myofibroblast formation and collagen synthesis.
    Mia MM; Bank RA
    J Cell Mol Med; 2015 Dec; 19(12):2780-92. PubMed ID: 26337045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β Promotes Metabolic Reprogramming in Lung Fibroblasts via mTORC1-dependent ATF4 Activation.
    O'Leary EM; Tian Y; Nigdelioglu R; Witt LJ; Cetin-Atalay R; Meliton AY; Woods PS; Kimmig LM; Sun KA; Gökalp GA; Mutlu GM; Hamanaka RB
    Am J Respir Cell Mol Biol; 2020 Nov; 63(5):601-612. PubMed ID: 32668192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic control of collagen synthesis.
    Guillard J; Schwörer S
    Matrix Biol; 2024 Nov; 133():43-56. PubMed ID: 39084474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical regulation of myofibroblast phenoconversion and collagen contraction.
    Hinz B; McCulloch CA; Coelho NM
    Exp Cell Res; 2019 Jun; 379(1):119-128. PubMed ID: 30910400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast Growth Factor 2 as an Antifibrotic: Antagonism of Myofibroblast Differentiation and Suppression of Pro-Fibrotic Gene Expression.
    Dolivo DM; Larson SA; Dominko T
    Cytokine Growth Factor Rev; 2017 Dec; 38():49-58. PubMed ID: 28967471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic inhibition of lactate production prevents myofibroblast differentiation.
    Kottmann RM; Trawick E; Judge JL; Wahl LA; Epa AP; Owens KM; Thatcher TH; Phipps RP; Sime PJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(11):L1305-12. PubMed ID: 26408551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cultured fetal fibroblasts have myofibroblast-associated characteristics and produce a fibrotic-like environment upon stimulation with TGF-β1: Is there a thin line between fetal scarless healing and fibrosis?
    Walraven M; Akershoek JJ; Beelen RH; Ulrich MM
    Arch Dermatol Res; 2017 Mar; 309(2):111-121. PubMed ID: 28004279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fighting the Fiber: Targeting Collagen in Lung Fibrosis.
    Staab-Weijnitz CA
    Am J Respir Cell Mol Biol; 2022 Apr; 66(4):363-381. PubMed ID: 34861139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 and Myofibroblast Apoptosis in Organ Fibrosis.
    McElhinney K; Irnaten M; O'Brien C
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.
    Hinz B; Lagares D
    Nat Rev Rheumatol; 2020 Jan; 16(1):11-31. PubMed ID: 31792399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of organ fibrosis.
    Jun JI; Lau LF
    J Clin Invest; 2018 Jan; 128(1):97-107. PubMed ID: 29293097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.